Britons with heart failure are being given larger doses of drugs at the start of their treatment after a global trial found ...

Findings from the SUMMIT, Altshock-2, and FAIR-HF2 trials were presented at the American College of Cardiology 2025 Annual ...

Tenax Therapeutics progresses levosimendan for PH-HFpEF with Phase 3 trials, aiming for a first-of-its-kind therapy. Click ...

Hydrogels, which are soft materials formed by cross-linking polymers, could have a variety of medical applications. In ...

Finerenone prevented new-onset atrial fibrillation or flutter in patients with chronic kidney disease and type 2 diabetes or ...

Use of routine thoracentesis in addition to medical therapy yielded no significant benefits for adults with heart failure and pleural effusions, according to a new study.

New Artificial Intelligence Tool Accelerates Disease Treatments Mar. 18 ... Mar. 17, 2025 — Patients who have been treated for heart failure and experience an improvement of their pump function ...

After an earlier trial showed patients with elevated levels of a cardiac stress marker benefited from its cell therapy, the firm shifted focus to this subset.

The largest study to date suggests that patients at high risk for heart attacks and strokes should begin immediate treatment ...

Breakthrough Cardiac Regeneration Research Offers Hope for the Treatment of Ischemic Heart Failure Mar. 7 ... cardiomyocyte proliferation offers new hope for the treatment of ischemic heart ...

Two local heart transplant patients who underwent treatment at WVU Medicine Wheeling Hospital shared how the procedure gave ...